What insurance policy changes affect CPT 47384?

There are 19 tracked policy changes affecting CPT 47384, including updates from CareSource, Anthem BCBS, Medical Mutual of Ohio. Each change may modify coverage criteria, reimbursement rates, or prior-authorization requirements.

Which payers have updated policy for CPT 47384?

Payers that have issued tracked updates for CPT 47384 include: CareSource, Anthem BCBS, Medical Mutual of Ohio, Blue Cross Blue Shield of North Dakota, Humana.

How do I get notified when CPT 47384 policy changes?

Create a free account at PolicyChanges.app and save a search filtered to CPT 47384. You will receive a daily digest email whenever a new policy change references this code.

Why do payers change policies for CPT 47384?

Payers revise policies for individual billing codes to align with updated clinical guidelines, CMS rule changes, fraud and abuse prevention measures, or network cost-management goals. Changes can affect medical necessity criteria, place-of-service restrictions, bundling rules, or whether a code requires prior authorization.

47384 — Destroying one or more liver tumors using percutaneous techniques like heat or chemical injection.: Insurance Policy Changes

47384 Insurance Policy Changes

CPT 47384, in plain terms, covers Destroying one or more liver tumors using percutaneous techniques like heat or chemical injection. CPT 47384 is referenced in 19 tracked payer policy changes from CareSource, Anthem BCBS, and 3 other payers. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for CPT 47384 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Medium impact

[Ohio] Precertification/prior authorization list change notification

Anthem BCBS·Effective Dec 1, 2026

Anthem Blue Cross and Blue Shield (Ohio) is adding 14 new services to its precertification/prior authorization requirements effective December 1, 2026. These additions include four specialized laboratory tests (Alzheimer's biomarkers, IBS serology, infectious disease sequencing, prostate cancer protein biomarkers), two irreversible electroporation procedures, six carotid sinus baroreceptor stimulation device codes, and two gene therapy treatments. All affected services will require prior authorization before billing to avoid claim denials.

47384 Insurance Policy Changes

[Georgia] Prior Authorization Requirement Update

[Ohio] Precertification/prior authorization requirement changes

[California] Precertification/prior authorization requirement changes

[Virginia] Prior authorization requirement changes

[Virginia] Precertification/prior authorization requirement changes

[Georgia] Precertification/prior authorization list change notification

[California] Prior authorization requirement changes

[California] Prior authorization requirement changes

[New York] Prior authorization requirement changes

[New York] Precertification/prior authorization requirement changes

[Ohio] Precertification/prior authorization requirement changes

[Virginia] Prior authorization requirement changes

[Georgia] Precertification/prior authorization requirement changes

[New York] Precertification/prior authorization list change notification

[Virginia] Precertification/prior authorization list change notification

[Ohio] Precertification/prior authorization list change notification

Mutual News April 2026 Newsletter

Medical Policy Updates

Irreversible Electroporation - Medicare Advantage (Revised)